Journal: Psychiatry Research 332 (2024)
Authors: Robert Hickson, Max W. Simonsen, Kenneth J. Miller, Michelle R. Madore
The background highlights the challenges faced by veterans with TRD, suicide risk, and PTSD symptoms, emphasizing the need for effective and durable treatment options.
The primary objective is to assess the durability of deep transcranial magnetic stimulation in improving symptoms of TRD, reducing suicide risk, and alleviating PTSD symptoms among veterans.
Data were retrospectively analyzed from 99 adult participants (Veterans). Veterans underwent 30 sessions of dTMS treatment including a tapering phase consisting of 6 sessions. The PHQ-9, PCL- 5, and BSS were administered to Veterans at four time points: pretreatment, post-treatment, three months after treatment, and six months after treatment.
There were clinically significant reductions in symptoms of depression (43.47%), PTSD (44.14%) and suicidal ideation (54.02%) at the six-month follow-up relative to pretreatment.
Results provide evidence of the impact and durability of Deep TMS on symptoms of MDD, PTSD, and suicidal ideation among Veterans with treatment-resistant depression.
